Patient Rating:

No Rating Available?

Francis M. Filloux, M.D.

Chief, Division of Pediatric Neurology

Specialties

Languages

  • English
  • French
  • Spanish

Clinical Details

Schedule An Appointment Clinical Office Address
(801) 587-7575 Clinical Neurosciences Center
175 North Medical Drive East
Salt Lake City, UT 84132
Map
(801) 587-7575 PCH Outpatient Services at Riverton
3773 West 12600 South
Riverton, UT 84065
(801) 587-7575 Primary Children's Hospital
Pediatric Neurology
100 N Mario Capecchi Drive
Salt Lake City, UT 84113

Bio

Francis Filloux, MD is Chief of the Division of Pediatric Neurology at the University of Utah School of Medicine and Primary Children’s Medical Center. He is responsible for administering the Division of Pediatric Neurology and is Program Training Director for the Pediatric Neurology Residency Program. Dr. Filloux is a general child neurologist who sees children with all forms of neurological disease, having special interest in tic disorders, Tourette's, and neurobehavioral problems.

Board Certification and Academic Information

Academic Departments Pediatrics - Professor
Neurology - Professor
Academic Divisions Pediatric Neurology
Board Certification American Board of Pediatrics (Pediatrics)
American Board of Psychiatry & Neurology (Sub: Child/Adol)
National Board of Medical Examiners

Academic Profile

Board Certification and Academic Information

Academic Departments Pediatrics - Professor
Neurology - Professor
Academic Divisions Pediatric Neurology
Board Certification American Board of Pediatrics (Pediatrics)
American Board of Psychiatry & Neurology (Sub: Child/Adol)
National Board of Medical Examiners

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 662-5691 Primary Children's Hospital
Pediatric Neurology
100 N Mario Capecchi Drive
Salt Lake City, UT 84113

Academic Bio

Francis M. Filloux, M.D. is the Chief of Pediatric Neurology at the University of Utah and Primary Children’s Medical Center in Salt Lake City, UT where he directs a vibrant, growing subspecialty group dedicated to the care of children with neurological disorders throughout the Intermountain West. He has been the Program Training Director for the Pediatric Neurology residency program, and is an active clinician and educator. Dr. Filloux’ current scholarly interests include pediatric neurology education, health care quality and improvement with reference to the neurological care for children, and the seizure and neurological characteristics of children with congenital genetic syndromes.

Dr. Filloux received his undergraduate education at the University of California, San Diego and his M.D. from University of California, Los Angeles School of Medicine. After completing postgraduate training in pediatrics and neurology with specialization in child neurology at the University of Utah, he served as a post-doctoral fellow in neuropharmacology under the direction of James Wamsley, Ph.D. During the first phase of his academic career he studied the neurochemical development of the basal ganglia and the ontogeny of calcium channels in vertebrate brain. He has developed specialized expertise in the evaluation and care of children with movement disorders, including Tourette syndrome and related conditions.

He currently serves on the editorial board of the Journal of Child Neurology and continues to find enjoyment in teaching medical students, residents and colleagues in the principles of neurological evaluation and diagnosis and in the breadth of clinical problems in pediatric neurology. His greatest professional satisfaction relates to the recruitment and training of bright young pediatric neurologists here at the University of Utah.

Education

Education History

Type School Degree
Fellowship University of Utah School of Medicine
Neuropharmacology
Fellow
Chief Resident University of Utah School of Medicine
Pediatric Neurology
Chief Resident
Residency University of Utah School of Medicine
Pediatric Neurology
Resident
Residency University of Utah School of Medicine
Pediatrics
Resident
Internship University of Utah School of Medicine
Pediatrics
Intern
Professional Medical University of California - Los Angeles
Medicine
M.D.
Undergraduate University of California at San Diego
Anthropology
B.A.

Publications

Selected Provider Publications

Journal Article

  1. Recessive mutations in EPG5 cause Vici syndrome, a multisystem disorder with defective autophagy.Cullup T, Kho AL, Dionisi-Vici C, Brandmeier B, Smith F, Urry Z, Simpson MA, Yau S, Bertini E, McClelland V, Al-Owain M, Koelker S, Koerner C, Hoffmann GF, Wijburg FA, ten Hoedt AE, Rogers RC, Manchester D, Miyata R, Hayashi M, Said E, Soler D, Kroisel PM, Windpassinger C, Filloux FM, Al-Kaabi S, Hertecant J, Del Campo M, Buk S, Bodi I, Goebel HH, Sewry CA, Abbs S, Mohammed S, Josifova D, Gautel M, Jungbluth H (2013). Recessive mutations in EPG5 cause Vici syndrome, a multisystem disorder with defective autophagy. Nat Genet, 45(1), 83-7.
  2. Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah.Stockmann C, Ampofo K, Byington CL, Filloux F, Hersh AL, Blaschke AJ, Cowan P, Korgenski K, Mason EO, Pavia AT (2013). Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah. Pediatrics, 132(3), 421-8.
  3. Occurrence and clinical features of epileptic and non-epileptic paroxysmal events in five children with Pallister-Killian syndrome.Filloux FM, Carey JC, Krantz ID, Ekstrand JJ, Candee MS (2012). Occurrence and clinical features of epileptic and non-epileptic paroxysmal events in five children with Pallister-Killian syndrome. Eur J Med Genet, 55(5), 367-73.
  4. Seizure characteristics in Pallister-Killian syndrome.Candee MS, Carey JC, Krantz ID, Filloux FM (2012). Seizure characteristics in Pallister-Killian syndrome. Am J Med Genet A, 158A(12), 3026-32.
  5. Bonkowsky JL, Nelson C, Kingston JL, Filloux FM, Mundorff MB, Srivastava R (2010). The Burden of Inherited Leukodystrophies in Children. Neurology, 75(8), 718-725.
  6. Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy.Holsti M, Dudley N, Schunk J, Adelgais K, Greenberg R, Olsen C, Healy A, Firth S, Filloux F (2010). Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy. Arch Pediatr Adolesc Med, 164(8), 747-53.
  7. Seizures In Children Following an Apparent Life-threatening Event.Bonkowsky JL, Guenther E, Srivastava R, Filloux FM (2009). Seizures In Children Following an Apparent Life-threatening Event. J Child Neurol, 24(6), 709-13.
  8. Singh NA, Pappas C, Dahle EJ, Claes LR, Pruess TH, De Jonghe P, Thompson J, Dixon M, Gurnett C, Peiffer A, White HS, Filloux F, Leppert MF (2009). A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome. PLoS Genet, 5(9), e1000649.
  9. Death, child abuse, and adverse neurological outcome of infants after an apparent life-threatening event.Bonkowsky JL, Guenther E, Filloux FM, Srivastava R (2008). Death, child abuse, and adverse neurological outcome of infants after an apparent life-threatening event. Pediatrics, 122(1), 125-31.
  10. Prehospital intranasal midazolam for the treatment of pediatric seizures.Holsti M, Sill BL, Firth SD, Filloux FM, Joyce SM, Furnival RA (2007). Prehospital intranasal midazolam for the treatment of pediatric seizures. Pediatr Emerg Care, 23(3), 148-53.
  11. Efficacy of the ketogenic diet as a treatment option for epilepsy: meta-analysis.Henderson CB, Filloux FM, Alder SC, Lyon JL, Caplin DA (2006). Efficacy of the ketogenic diet as a treatment option for epilepsy: meta-analysis. J Child Neurol, 21(3), 193-8.
  12. Development of performance indicators for the primary care management of pediatric epilepsy: expert consensus recommendations based on the available evidence.Caplin DA, Rao JK, Filloux F, Bale JF, Van Orman C (2006). Development of performance indicators for the primary care management of pediatric epilepsy: expert consensus recommendations based on the available evidence. Epilepsia, 47(12), 2011-9.
  13. Infant botulism in the age of botulism immune globulin.Thompson JA, Filloux FM, Van Orman CB, Swoboda K, Peterson P, Firth SD, Bale JF Jr (2005). Infant botulism in the age of botulism immune globulin. Neurology, 64(12), 2029-32.
  14. Case Series-Cerebral sinovenous thrombosis in children: another reason to treat iron deficiency anemia.Benedict SL, Bonkowsky JL, Thompson JA, Van Orman CB, Boyer RS, Bale JF Jr, Filloux FM (2004). Case Series-Cerebral sinovenous thrombosis in children: another reason to treat iron deficiency anemia. J Child Neurol, 19(7), 526-31.
  15. Singh NA, Westenskow P, Charlier C, Pappas C, Leslie J, Dillon J, The BFNC Physician Consortium Filloux FM, et al Lepper MF (2003). KCNQ2 and KCNQ3 Potassium Channel Genes in Benign Familial Neonatal Convulsions: Expansion of the functional and Mutation Spectrum. Brain, 126, 2726-2737.

Review

  1. Movement disorders in children and adolescents.McMahon WM, Filloux FM, Ashworth JC, Jensen J (2002). Movement disorders in children and adolescents. [Review]. Neurol Clin, 20(4), 1101-24, vii-viii.

Book Chapter

  1. McMahon WM, Leppert M, Filloux F, van de Wetering BJM, Hasstedt S (1992). Tourette Symptoms in 161 Related Family Members. In Chase TN, Friedhoff AJ, Cohen DJ (Ed.), Tourette Syndrome: Genetics, Neurobiology and Treatment (58, pp. 159-165). New York: Adv. Neurol, Raven Press.

Case Report

  1. Splenial corpus callosum lesion and hemifield visual color anomia associated with intracranial hypertension.Bonkowsky JL, Filloux FM, Warner JE (2007). Splenial corpus callosum lesion and hemifield visual color anomia associated with intracranial hypertension. J Child Neurol, 22(9), 1132-4.
  2. Herpes simplex virus central nervous system relapse during treatment of infantile spasms with corticotropin.Bonkowsky JL, Filloux FM, Byington CL (2006). Herpes simplex virus central nervous system relapse during treatment of infantile spasms with corticotropin. Pediatrics, 117(5), e1045-8.
  3. Cannon G, Caravati EM, Filloux F (2003). Hydrogen Peroxide Neurotoxicity in Childhood: Case Report with Unique MRI Features. J Child Neurol, 18, 805-8.

Clinical Trials

Clinical Trials

Video & News

The Scope Health Sciences Radio

Video